Literature DB >> 21658873

A probe-based method for confirmation of methicillin-resistant Staphylococcus aureus and detection of Panton-Valentine leukocidin and tst virulence genes.

Ashok Srinivasan1, Matthew J Bankowski, Steven E Seifried, Sadao Jinno, Rosalie Perkins, Seema Singh, Claire Ying, Alan D Tice, Wesley Kim, Randall T Hayden.   

Abstract

Probe-based detection of mecA, lukS/F-PV (Panton-Valentine leukocidin), and tst virulence genes in 435 isolates of Staphylococcus aureus had comparable sensitivity and specificity to end-point polymerase chain reaction as a reference standard.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21658873      PMCID： PMC4719149          DOI： 10.1016/j.diagmicrobio.2011.04.005

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  17 in total

1.  Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk.

Authors:  B C Herold; L C Immergluck; M C Maranan; D S Lauderdale; R E Gaskin; S Boyle-Vavra; C D Leitch; R S Daum
Journal:  JAMA       Date:  1998-02-25       Impact factor: 56.272

2.  Multiplex PCR for simultaneous identification of Staphylococcus aureus and detection of methicillin and mupirocin resistance.

Authors:  E Pérez-Roth; F Claverie-Martín; J Villar; S Méndez-Alvarez
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

3.  Evaluation of mupA EVIGENE assay for determination of high-level mupirocin resistance in Staphylococcus aureus.

Authors:  Anne K I Rasmussen; Robert L Skov; Richard A Venezia; Jennifer K Johnson; Henrik Stender
Journal:  J Clin Microbiol       Date:  2010-09-01       Impact factor: 5.948

4.  Evaluation of a new 3-h hybridization method for detecting the mecA gene in Staphylococcus aureus and comparison with existing genotypic and phenotypic susceptibility testing methods.

Authors:  R L Skov; L V Pallesen; R L Poulsen; F Espersen
Journal:  J Antimicrob Chemother       Date:  1999-04       Impact factor: 5.790

5.  Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease.

Authors:  Sophie Jarraud; Christophe Mougel; Jean Thioulouse; Gerard Lina; Hélène Meugnier; Françoise Forey; Xavier Nesme; Jerome Etienne; François Vandenesch
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

6.  Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia.

Authors:  G Lina; Y Piémont; F Godail-Gamot; M Bes; M O Peter; V Gauduchon; F Vandenesch; J Etienne
Journal:  Clin Infect Dis       Date:  1999-11       Impact factor: 9.079

7.  A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates.

Authors:  M S Bergdoll; B A Crass; R F Reiser; R N Robbins; J P Davis
Journal:  Lancet       Date:  1981-05-09       Impact factor: 79.321

8.  Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus infections in children with cancer.

Authors:  Ashok Srinivasan; Steven Seifried; Liang Zhu; Deo K Srivastava; Patricia M Flynn; Jerry L Shenep; Matthew J Bankowski; Randall T Hayden
Journal:  Pediatr Blood Cancer       Date:  2009-12-15       Impact factor: 3.167

9.  Detection of methicillin resistance in coagulase-negative staphylococci and in staphylococci directly from simulated blood cultures using the EVIGENE MRSA Detection Kit.

Authors:  Ane B Poulsen; Robert Skov; Lars V Pallesen
Journal:  J Antimicrob Chemother       Date:  2003-02       Impact factor: 5.790

10.  Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence.

Authors:  Francois Vandenesch; Timothy Naimi; Mark C Enright; Gerard Lina; Graeme R Nimmo; Helen Heffernan; Nadia Liassine; Michèle Bes; Timothy Greenland; Marie-Elisabeth Reverdy; Jerome Etienne
Journal:  Emerg Infect Dis       Date:  2003-08       Impact factor: 6.883
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.